Paradigm, Galaxy back biotech merger to pivot to $888M Hyperliquid treasury strategy
Sonnet BioTherapeutics, a publicly listed biotech firm, has announced a definitive merger agreement with Rorschach I LLC, a newly formed entity backed by Atlas Merchant Capital and other crypto-focuse...